Case study

Conquering the oncology marketspace

We are experts in hematology and oncology, especially in value and access communications. Our team of clinical experts and board-certified oncology pharmacists have a deep understanding of the complexities of cancer care and the unique challenges facing novel therapies like CAR-T and cell and gene therapies.

Oncology expertise to support market access for life-saving therapies

We are experts in hematology and oncology, especially in value and access communications. Our team of clinical experts and board-certified oncology pharmacists have a deep understanding of the complexities of cancer care and the unique challenges facing novel therapies like CAR-T and cell and gene therapies.
* Available in English only.

Related resources

Webinar

The evolving anti-obesity medication market: Payer trends, policy shifts, and access strategies

Article

Navigating the nuances and complexities of the European reimbursement landscape

Article

AI-powered tools for pricing: Key takeaways from ISPOR Europe 2025